Sage has its time; a large-scale open access resource for systems biologists
As highlighted in the latest issue of Nature Reviews in Drug Discovery, the incubation phase of a new Open Access platform called Sage (www.sagebase.org) should begin on 1 July, 2009. The aim of this initiative, led by Stephen Friend and Eric Schadt who are leaving Merck to run it, is ‘to integrate large-scale biological information into models and then enable other scientists to leverage that information in an open access way’. It starts with a large chunk of data and information (especially expression profiling data) that they bring to the party. [...]